Intermountain Risk Score and Trauma

Trauma Clinical Trial

Official title:

The Intermountain Risk Score's Association With Mortality Prediction in Trauma Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02011412
• Other study ID #: 1024710
• Status: Completed
• Phase: N/A
• First received: November 6, 2013
• Last updated: February 22, 2016
• Start date: October 2013
• Est. completion date: December 2015

Study information

• Verified date: February 2016
• Source: Intermountain Health Care, Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The investigators hypothesize that a risk score composed of age, sex, and the components of commonly ordered laboratory panels will be predictive of mortality in trauma patients, and will help improve clinicians' ability to make more accurate mortality predictions at the time of admission.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 400
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient presents to Intermountain Medical Center as a Level I or Level II trauma activation.

• Age =18

Exclusion Criteria:

• Patients who are not admitted to the hospital

1. Patients who expire in the Emergency Department

2. Patients who are discharged to home from the Emergency Department

• Patients who do not have a complete blood count and basic metabolic profile drawn in the Emergency Department as part of routine clinical care.

• Patients who enter the hospital as "trauma consults." These patients have traumatic injuries, and are often admitted to the trauma service, but the severity of their trauma is not thought to warrant trauma team activation.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Injury
• Trauma
• Wounds and Injuries

Locations

Country	Name	City	State
United States	Intermountain Medical Center	Murray	Utah

Sponsors (1)

Lead Sponsor	Collaborator
Intermountain Health Care, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	all cause mortality	To determine whether the Intermountain Risk Score accurately predicts 30 day mortality and one year mortality in trauma patients.	30 days	No
Primary	all cause mortality	measure the ability of the Intermountain Risk Score to predict all cause mortality at one year after the traumatic event	1 year	No
Secondary	experienced clinicians mortality prediction	compare the IMRS to experienced clinicians' ability to predict mortality at 30 days	30 days	No
Secondary	Experienced Clinicians' mortality prediction	compare the IMRS to experienced clinicians' ability to predict mortality at 1 year	1 year	No